Data on Carbonic Anhydrase Inhibitor Anticonvulsants Reported by a Researcher at Hannover Medical School (Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship).

A recent study from Hannover Medical School discusses the effects of acetazolamide (AZM), a carbonic anhydrase inhibitor anticonvulsant, on urinary excretion of various substances. The research highlights the pharmacological properties of AZM, its impact on amino acids, nitrite, nitrate, and malondialdehyde excretion, and potential implications for oxidative stress. The study also delves into tolerance development and drug resistance to AZM in chronic use. For more details, refer to the Journal of Enzyme Inhibition and Medicinal Chemistry. [Extracted from the article]